Amgen (AMGN)

Nasdaq Health Care Biotechnology S&P 500Nasdaq-100Dow 30

$460.42

+0.14 (+0.03%)

Close of Nov 06, 2026 · end-of-day data

Source: Amgen's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$22.99B	$22.85B	$23.75B	$23.36B	$25.42B	$25.98B	$26.32B	$28.19B	$33.42B	$36.75B
Cost of revenue	$4.16B	$4.07B	$4.10B	$4.36B	$6.16B	$6.45B	$6.41B	$8.45B	$12.86B	$12.04B
Gross profit	$18.83B	$18.78B	$19.65B	$19.01B	$19.27B	$19.52B	$19.92B	$19.74B	$20.57B	$24.71B
Research & development	$3.84B	$3.56B	$3.74B	$4.12B	$4.21B	$4.82B	$4.43B	$4.78B	$5.96B	$7.27B
Selling, general & admin	$5.06B	$4.87B	$5.33B	$5.15B	$5.73B	$5.37B	$5.41B	$6.18B	$7.10B	$7.05B
Operating income	$9.79B	$9.97B	$10.26B	$9.67B	$9.14B	$7.64B	$9.57B	$7.90B	$7.26B	$9.08B
Interest expense	$1.26B	$1.30B	$1.39B	$1.29B	$1.26B	$1.20B	$1.41B	$2.88B	$3.15B	$2.75B
Pre-tax income	$9.16B	$9.60B	$9.54B	$9.14B	$8.13B	$6.70B	$7.35B	$7.86B	$4.61B	$8.98B
Income tax	$1.44B	$7.62B	$1.15B	$1.30B	$869.00M	$808.00M	$794.00M	$1.14B	$519.00M	$1.26B
Net income	$7.72B	$1.98B	$8.39B	$7.84B	$7.26B	$5.89B	$6.55B	$6.72B	$4.09B	$7.71B
EBITDA	$11.90B	$11.93B	$12.21B	$11.88B	$12.74B	$11.04B	$12.98B	$11.97B	$12.85B	$14.25B
EPS (basic)	$10.32	$2.71	$12.70	$12.96	$12.40	$10.34	$12.18	$12.56	$7.62	$14.33
EPS (diluted)	$10.24	$2.69	$12.62	$12.88	$12.31	$10.28	$12.11	$12.49	$7.56	$14.23
Diluted shares	754.00M	735.00M	665.00M	609.00M	590.00M	573.00M	541.00M	538.00M	541.00M	542.00M
Gross margin	81.9%	82.2%	82.7%	81.4%	75.8%	75.2%	75.7%	70.0%	61.5%	67.2%
Operating margin	42.6%	43.6%	43.2%	41.4%	35.9%	29.4%	36.3%	28.0%	21.7%	24.7%
Net margin	33.6%	8.7%	35.3%	33.6%	28.6%	22.7%	24.9%	23.8%	12.2%	21.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$3.24B	$3.80B	$6.95B	$6.04B	$6.27B	$7.99B	$7.63B	$10.94B	$11.97B	$9.13B
Short-term investments	—	$37.88B	$22.36B	$2.87B	$4.38B	$48.00M	$1.68B	$0	—	—
Receivables	$3.17B	$3.24B	$3.58B	$4.06B	$4.53B	$4.89B	$5.56B	$7.27B	$6.78B	$9.57B
Inventory	$2.75B	$2.83B	$2.94B	$3.58B	$3.89B	$4.09B	$4.93B	$9.52B	$7.00B	$6.22B
Total current assets	$46.01B	$49.48B	$37.62B	$18.44B	$21.14B	$19.39B	$22.19B	$30.33B	$29.03B	$29.06B
Goodwill	$14.76B	$14.76B	$14.70B	$14.70B	$14.69B	$14.89B	$15.53B	$18.63B	$18.64B	$18.68B
Total assets	$77.63B	$79.95B	$66.42B	$59.71B	$62.95B	$61.16B	$65.12B	$97.15B	$91.84B	$90.59B
Total current liabilities	$11.20B	$9.02B	$13.49B	$12.84B	$11.65B	$12.18B	$15.69B	$18.39B	$23.10B	$25.49B
Short-term debt	$4.40B	$1.15B	$4.42B	$2.95B	$91.00M	$87.00M	$1.59B	$1.44B	$3.55B	$4.60B
Long-term debt	$30.19B	$34.19B	$29.51B	$26.95B	$32.90B	$33.22B	$37.35B	$63.17B	$56.55B	$50.01B
Total debt	$34.60B	$35.34B	$33.93B	$29.90B	$32.99B	$33.31B	$38.95B	$64.61B	$60.10B	$54.60B
Total liabilities	$47.75B	$54.71B	$53.92B	$50.03B	$53.54B	$54.47B	$61.46B	$90.92B	$85.96B	$81.93B
Shareholders' equity	$29.88B	$25.24B	$12.50B	$9.67B	$9.41B	$6.70B	$3.66B	$6.23B	$5.88B	$8.66B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$10.35B	$11.18B	$11.30B	$9.15B	$10.50B	$9.26B	$9.72B	$8.47B	$11.49B	$9.96B
Capital expenditures	$738.00M	$664.00M	$738.00M	$618.00M	$608.00M	$880.00M	$936.00M	$1.11B	$1.10B	$1.86B
Free cash flow	$9.62B	$10.51B	$10.56B	$8.53B	$9.89B	$8.38B	$8.79B	$7.36B	$10.39B	$8.10B
Investing cash flow	-$8.66B	-$4.02B	$14.34B	$5.71B	-$5.40B	$733.00M	-$6.04B	-$26.20B	-$1.05B	-$1.94B
Financing cash flow	-$2.60B	-$6.59B	-$22.49B	-$15.77B	-$4.87B	-$8.27B	-$4.04B	$21.05B	-$9.41B	-$10.86B
Dividends paid	$3.00B	$3.37B	$3.51B	$3.51B	$3.75B	$4.01B	$4.20B	$4.56B	$4.83B	$5.12B
Share buybacks	$2.96B	$3.16B	$17.79B	$7.70B	$3.49B	$4.97B	$6.36B	$0	$200.00M	$0
Stock-based compensation	$311.00M	$329.00M	$311.00M	$308.00M	$330.00M	$341.00M	$401.00M	$431.00M	$530.00M	$494.00M
Depreciation & amortization	$2.10B	$1.96B	$1.95B	$2.21B	$3.60B	$3.40B	$3.42B	$4.07B	$5.59B	$5.17B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$8.20B	$7.45B	$8.39B	$8.50B	$9.09B	$8.15B	$9.18B	$9.56B	$9.87B	$8.62B	$10.05B	$10.37B
Cost of revenue	$3.11B	$3.20B	$3.24B	$3.31B	$3.11B	$2.97B	$3.01B	$3.08B	$2.98B	$2.74B	$2.81B	$2.79B
Gross profit	$5.08B	$4.25B	$5.15B	$5.19B	$5.97B	$5.18B	$6.17B	$6.47B	$6.89B	$5.87B	$7.24B	$7.58B
Research & development	$1.53B	$1.34B	$1.45B	$1.45B	$1.72B	$1.49B	$1.74B	$1.90B	$2.14B	$1.72B	$1.87B	$2.11B
Selling, general & admin	$2.27B	$1.81B	$1.78B	$1.62B	$1.88B	$1.69B	$1.69B	$1.72B	$1.95B	$1.60B	$1.75B	$1.68B
Operating income	$1.27B	$991.00M	$1.91B	$2.05B	$2.31B	$1.18B	$2.66B	$2.53B	$2.72B	$2.67B	$3.51B	$3.71B
Interest expense	$821.00M	$824.00M	$808.00M	$776.00M	$747.00M	$723.00M	$694.00M	$685.00M	$653.00M	$657.00M	$673.00M	$653.00M
Pre-tax income	$852.00M	-$68.00M	$794.00M	$3.10B	$782.00M	$1.97B	$1.57B	$3.92B	$1.51B	$2.08B	$2.77B	$4.69B
Income tax	$85.00M	$45.00M	$48.00M	$271.00M	$155.00M	$243.00M	$136.00M	$705.00M	$181.00M	$265.00M	$393.00M	$822.00M
Net income	$767.00M	-$113.00M	$746.00M	$2.83B	$627.00M	$1.73B	$1.43B	$3.22B	$1.33B	$1.82B	$2.38B	$3.86B
EBITDA	$2.65B	$2.39B	$3.31B	$3.44B	$3.71B	$2.56B	$4.00B	$3.83B	$3.85B	$3.78B	$4.63B	$4.83B
EPS (basic)	$1.44	$-0.21	$1.39	$5.27	$1.17	$3.22	$2.66	$5.98	$2.47	$3.37	$4.40	$7.14
EPS (diluted)	$1.43	$-0.21	$1.38	$5.22	$1.16	$3.20	$2.65	$5.93	$2.46	$3.34	$4.37	$7.08
Diluted shares	—	536.00M	541.00M	542.00M	—	541.00M	541.00M	542.00M	—	544.00M	544.00M	546.00M
Gross margin	62.0%	57.0%	61.4%	61.1%	65.7%	63.6%	67.2%	67.8%	69.8%	68.2%	72.0%	73.1%
Operating margin	15.5%	13.3%	22.8%	24.1%	25.4%	14.5%	28.9%	26.4%	27.6%	30.9%	35.0%	35.8%
Net margin	9.4%	-1.5%	8.9%	33.3%	6.9%	21.2%	15.6%	33.7%	13.5%	21.1%	23.6%	37.3%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$10.94B	$9.71B	$9.30B	$9.01B	$11.97B	$8.81B	$8.03B	$9.45B	$9.13B	$12.04B	$13.99B	$13.19B
Short-term investments	$0	—	—	—	—	—	—	—	—	—	—	—
Receivables	$7.27B	$6.78B	$6.93B	$7.32B	$6.78B	$8.13B	$8.70B	$8.49B	$9.57B	$9.14B	$10.23B	$10.35B
Inventory	$9.52B	$8.72B	$8.00B	$7.36B	$7.00B	$6.73B	$6.58B	$6.35B	$6.22B	$6.19B	$6.22B	$6.39B
Total current assets	$30.33B	$28.03B	$27.21B	$26.77B	$29.03B	$26.93B	$26.73B	$27.89B	$29.06B	$31.48B	$34.96B	$34.36B
Goodwill	$18.63B	$18.57B	$18.62B	$18.66B	$18.64B	$18.64B	$18.67B	$18.68B	$18.68B	$18.67B	$18.67B	$18.66B
Total assets	$97.15B	$92.98B	$90.91B	$90.88B	$91.84B	$89.37B	$87.90B	$90.14B	$90.59B	$92.50B	$95.64B	$96.05B
Total current liabilities	$18.39B	$19.71B	$21.52B	$20.31B	$23.10B	$23.01B	$20.48B	$21.79B	$25.49B	$24.95B	$25.50B	$23.23B
Short-term debt	$1.44B	$3.96B	$5.53B	$3.54B	$3.55B	$3.37B	$2.44B	$2.15B	$4.60B	$5.44B	$5.45B	$2.40B
Long-term debt	$63.17B	$60.06B	$57.12B	$56.85B	$56.55B	$54.01B	$53.76B	$52.43B	$50.01B	$51.89B	$51.86B	$51.61B
Total debt	$64.61B	$64.02B	$62.65B	$60.40B	$60.10B	$57.38B	$56.20B	$54.59B	$54.60B	$57.32B	$57.30B	$54.01B
Total liabilities	$90.92B	$87.96B	$84.98B	$83.36B	$85.96B	$83.16B	$80.47B	$80.52B	$81.93B	$83.31B	$83.95B	$81.70B
Shareholders' equity	$6.23B	$5.02B	$5.92B	$7.53B	$5.88B	$6.21B	$7.43B	$9.62B	$8.66B	$9.19B	$11.69B	$14.35B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$538.00M	$689.00M	$2.46B	$3.57B	$4.77B	$1.39B	$2.28B	$4.68B	$1.60B	$2.19B	$4.00B	$4.24B
Capital expenditures	$249.00M	$230.00M	$238.00M	$257.00M	$371.00M	$411.00M	$369.00M	$436.00M	$642.00M	$712.00M	$513.00M	$587.00M
Free cash flow	$289.00M	$459.00M	$2.22B	$3.31B	$4.40B	$980.00M	$1.91B	$4.25B	$961.00M	$1.48B	$3.49B	$3.65B
Investing cash flow	-$27.09B	-$217.00M	-$217.00M	-$210.00M	-$402.00M	-$447.00M	-$389.00M	-$414.00M	-$693.00M	-$716.00M	-$569.00M	-$649.00M
Financing cash flow	$2.75B	-$1.71B	-$2.65B	-$3.65B	-$1.41B	-$4.11B	-$2.67B	-$2.85B	-$1.23B	$1.44B	-$1.48B	-$4.39B
Dividends paid	$1.14B	$1.21B	$1.21B	$1.21B	$1.21B	$1.28B	$1.28B	$1.28B	$1.28B	$1.36B	$1.36B	$1.36B
Share buybacks	$0	—	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	$161.00M	$103.00M	$157.00M	$136.00M	$134.00M	$85.00M	$157.00M	$127.00M	$125.00M	$75.00M	$165.00M	$128.00M
Depreciation & amortization	$1.38B	$1.40B	$1.40B	$1.40B	$1.40B	$1.39B	$1.34B	$1.31B	$1.13B	$1.12B	$1.11B	$1.12B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.